Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway
US-8927241-B2 · Jan 6, 2015 · US
US9284570B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9284570-B2 |
| Application number | US-201113306633-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 29, 2011 |
| Priority date | Nov 30, 2010 |
| Publication date | Mar 15, 2016 |
| Grant date | Mar 15, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to recombinant expression of a steviol or steviol glycosides biosynthetic pathway enzymes in cells and the production of steviol or steviol glycosides.
Opening claim text (preview).
What is claimed is: 1. A method for producing steviol or steviol glycoside comprising: culturing an E. coli strain having balanced expression of (1) an upstream methylerythritol pathway (MEP) that produces isopentyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP), with respect to (2) a downstream pathway that produces steviol or steviol glycoside from said IPP and DMAPP, the downstream pathway comprising a recombinantly expressed copalyl diphosphate synthase (CPS), kaurene synthase (KS), a geranylgeranyl diphosphate synthase (GGPPS) kaurenoic acid 13-hydroxylase (KAH) and kaurene oxidase (KO), and optionally one or more Stevia UDP glycosyl transferase enzymes; wherein said balanced expression is obtained by increasing or decreasing the expression level of a downstream pathway module and increasing or decreasing the expression level of an upstream pathway module together in E. coli , and identifying an E. coli strain with higher production of steviol or steviol glycoside and/or lower accumulation of indole as having balanced expression. 2. The method of claim 1 , wherein the copalyl diphosphate synthase (CPS) enzyme is a Stevia enzyme. 3. The method of claim 1 , wherein the kaurene synthase (KS) enzyme is a Stevia enzyme. 4. The method of claim 1 , wherein the GGPPS enzyme is a Taxus enzyme or a Stevia enzyme. 5. The method of claim 1 , wherein the upstream pathway module comprises dxs, idi, ispD, and ispF genes of the MEP pathway. 6. The method of claim 5 , wherein the upstream pathway module comprises dxs, idi, ispD and ispF genes of the MEP pathway expressed as the operon dxs-idi-ispD-ispF. 7. The method of claim 1 , wherein the downstream module comprises the gene encoding the copalyl diphosphate synthase (CPS) enzyme, the gene encoding the kaurene synthase (KS) enzyme and the gene encoding the GGPPS enzyme co-expressed on an operon. 8. The method of claim 1 , wherein the downstream module further comprises kaurene oxidase (KO) and kaurenoic acid 13-hydroxylase (KAH) enzymes co-expressed on an operon, optionally each as fusions with a cytochrome P450 reductase. 9. The method of claim 1 , wherein the expression of the upstream pathway module and the expression of the downstream pathway module are balanced by one or more of: increasing or decreasing promoter strengths, increasing or decreasing gene or operon copy number, and changing the position of genes within the module. 10. The method of claim 9 , wherein one or more operons is integrated into the E. coli genome. 11. The method of claim 1 , wherein the KAH and KO are Stevia enzymes. 12. The method of claim 11 , wherein the KAH and/or KO comprise catalytically active portions fused to a Stevia cytochrome P450 reductase enzyme. 13. The method of claim 12 , wherein the KAH and KO enzymes have an N-terminal truncation and contain the N-terminal peptide sequence MALLLAVF (SEQ ID NO: 16). 14. The method of claim 1 , further comprising recovering the steviol or steviol glycoside. 15. The method of claim 14 , wherein the steviol or steviol glycoside is recovered from the gas phase of the culture by adding an organic layer.
Copalyl diphosphate synthase (5.5.1.12) · CPC title
Hydroxy-carboxylic acids · CPC title
using catalysts, e.g. selective catalysts · CPC title
Ent-kaurene oxidase (1.14.13.78) · CPC title
Algae (unicellular algae C12N1/12) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.